Designing HITL Workflows That Actually Work

Chapter 14 of the source material behind this module opens with two mistakes it calls the most consequential an organisation can make when implementing AI in pharmacovigilance, and they’re worth stating exactly as identified: treating AI as a replacement for human judgment rather than an extension of it, and implementing human oversight as a compliance checkbox — someone clicking "approved" on an AI output without genuine review — rather than as a real quality safeguard. Every principle in this lesson exists to prevent one or the other.

A HITL workflow is only as good as the actual review it enables, and that depends entirely on how it’s designed — not on whether "human review" appears somewhere in a process diagram. Workflows built around speed targets, volume metrics, or throughput bonuses produce HITL in name only: a reviewer under enough time pressure clicks "approve" without genuinely re-deriving the judgment, which satisfies the letter of every regulatory framework in this module while defeating its entire purpose.

Interface design turns out to matter enormously here, more than it might seem. Reviewers need to see the source document and the AI-proposed fields simultaneously, side by side — not the extracted data alone, and not the source alone first followed by the extraction later. A reviewer who sees only the AI’s output, without the source right next to it, cannot meaningfully validate anything; they’re reviewing the AI’s summary of itself. High-confidence fields can be pre-populated to save time, but low-confidence fields need to be visibly flagged for deliberate attention rather than blending invisibly into the rest of the form.

A genuinely well-designed workflow makes the human’s contribution explicit and specific at every single stage, rather than one vague "review" step at the end. This is worth internalising as a checklist: an AI agent reads a source and structures it with confidence scores (no human contribution needed yet); a reviewer opens the case alongside the original source (this is the step that makes everything after it possible); the reviewer validates every extracted field against that source, correcting and adding what’s missing (the primary human contribution, genuinely undelegatable); for ambiguous cases, the reviewer makes the clinical judgment call on seriousness, expectedness, and causality that Module 6 built in depth (always a human decision, never AI’s to make); the reviewer makes the final MedDRA coding decision, with mandatory second review for serious cases (Module 4’s discipline, still fully in force); every AI-drafted narrative gets read against the source and edited (Module 5’s discipline, unchanged); and the reviewer confirms every field, checks the timeline, and authorises submission — always a named human act, never automated, regardless of how good the AI upstream of it has become.